Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Asset Utilization Ratio (2016 - 2026)

Tandem Diabetes Care filings provide 12 years of Asset Utilization Ratio readings, the most recent being 1.16 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 18.35% to 1.16 in Q4 2025 year-over-year; TTM through Dec 2025 was 1.16, a 18.35% increase, with the full-year FY2025 number at 1.1, up 12.1% from a year prior.
  • Asset Utilization Ratio hit 1.16 in Q4 2025 for Tandem Diabetes Care, roughly flat from 1.15 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.16 in Q4 2025 to a low of 0.74 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.81 (2021), compared with a mean of 0.87.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 37.43% in 2021 and later skyrocketed 31.49% in 2025.
  • Tandem Diabetes Care's Asset Utilization Ratio stood at 0.8 in 2021, then dropped by 4.72% to 0.76 in 2022, then increased by 3.57% to 0.79 in 2023, then increased by 23.6% to 0.98 in 2024, then increased by 18.35% to 1.16 in 2025.
  • The last three reported values for Asset Utilization Ratio were 1.16 (Q4 2025), 1.15 (Q3 2025), and 1.11 (Q2 2025) per Business Quant data.